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Rapid advances in genomic technologies have led to a wealth
of diverse data, from which novel discoveries can be gleaned
through the application of robust statistical and computational
methods. Here, we describe GeneFishing, a semisupervised com-
putational approach to reconstruct context-specific portraits of
biological processes by leveraging gene–gene coexpression infor-
mation. GeneFishing incorporates multiple high-dimensional sta-
tistical ideas, including dimensionality reduction, clustering, sub-
sampling, and results aggregation, to produce robust results. To
illustrate the power of our method, we applied it using 21 genes
involved in cholesterol metabolism as “bait” to “fish out” (or
identify) genes not previously identified as being connected to
cholesterol metabolism. Using simulation and real datasets, we
found that the results obtained through GeneFishing were more
interesting for our study than those provided by related gene pri-
oritization methods. In particular, application of GeneFishing to
the GTEx liver RNA sequencing (RNAseq) data not only reidenti-
fied many known cholesterol-related genes, but also pointed to
glyoxalase I (GLO1) as a gene implicated in cholesterol meta-
bolism. In a follow-up experiment, we found that GLO1 knock-
down in human hepatoma cell lines increased levels of cellu-
lar cholesterol ester, validating a role for GLO1 in cholesterol
metabolism. In addition, we performed pantissue analysis by
applying GeneFishing on various tissues and identified many
potential tissue-specific cholesterol metabolism-related genes.
GeneFishing appears to be a powerful tool for identifying related
components of complex biological systems and may be used
across a wide range of applications.
context-specific gene functional groups | cholesterol metabolism |
gene prioritization | gene pathways | pantissue analysis
Systems biology was first introduced into the language ofmodern biology in the early 21st century (1, 2). It is an inter-
disciplinary research field that focuses on understanding a big
picture of how small cell components (such as RNAs and pro-
teins) interact in complex biological systems. Over the past 2
decades, along with the rapid development of high-throughput
experimental and computational tools, the field of systems biol-
ogy has advanced greatly. This advance has been driven to a
considerable extent by the collaboration of researchers in biology
and quantitative fields. Large collaborative efforts have made
significant contributions to systems biology research under many
aspects: experimental, computational, and philosophical (3–5).
In this article, we propose a tool that should be helpful in
one of these aspects—the study of reconstructing comprehen-
sive context-specific portraits of biological processes using gene
expression data and the change in such portraits across differ-
ent contexts (such as tissue types, disease status, and so on). The
variability in such portraits gives rise to the diverse functional
behaviors of biological systems.
The types of questions that we tackle here have been and con-
tinue to be considered extensively in the literature under the
heading of “gene prioritization” for a specific biological process
or pathway. An excellent review of developments up to 2012 and
exposition of developments to come may be found in referenced
literatures (6). In particular, they point to the general “guilt by
association” principle and extensions of the principle that they
call “edge prioritization” or “generating hypotheses about poten-
tial interactions between top candidates and seed (bait) genes.”
Although many tools [such as GIANT (7) and ENDEAVOUR
(8)] have used this principle and been successful in many appli-
cations (7–12), some issues need to be addressed further. One
issue is the low signal-to-noise ratio in data. On the one hand,
it is believed that the great majority of genes across the whole
genome have no relationship with the process of interest. On
the other hand, gene–gene coexpression, one of the most highly
used measures in guilt by association procedures, often generates
results with high false positive rates. Thus, when whole-genome
gene–gene coexpression is considered, the sheer number of gene
pairs that are coexpressed randomly may outweigh that of gene
pairs with coexpression that reflects underlying biology. Another
issue is the selection of “seed (bait)” genes. Although this is
not a statistical issue (i.e., it largely depends on the biological
question of interest), it calls for an assessment of the sensitivity
of the conclusions to choice of the bait set. The current litera-
ture lacks such systematic sensitivity analysis. Our view is that a
successful statistical method needs to produce scientific conclu-
sions that are in part unexpected on the basis of current (maybe
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imperfect) knowledge and in part conform to well-known biol-
ogy. These 2 issues call for gene prioritization methods that
are effective for the analysis of large noisy datasets with sparse
signal and are also robust against possible noise in the seed
(bait) genes.
To address these issues, we combine several high-dimensional
statistical techniques, including dimensionality reduction, clus-
tering, subsampling, and aggregation of results (motivated by a
bagging-like idea), in a way to develop a method that we call
GeneFishing. We attempt to identify all genes in the genome
with an expression activity pattern related to that of most of
the bait genes under the same conditions. We note that, while
datasets may be “large” in terms of the number of measured
variables (i.e., genome-wide genetic features), the sample size
of these data could be limited (e.g., there might be only hun-
dreds of individuals per dataset). Thus, powerful techniques
for big data, such as deep learning, may be an overkill, while
approaches that effectively combine modern and traditional sta-
tistical ideas for analyzing both big and small data may be
more effective.
We evaluated our method through an application to choles-
terol metabolism, a highly characterized biological process.
Using a set of preidentified 21 “bait genes,” all of which have
known roles in cholesterol metabolism, we applied GeneFish-
ing to 3 independent RNAseq (RNA sequencing) datasets of
human lymphoblastoid cell lines and found that our approach
not only identified other genes with known roles in choles-
terol metabolism but also, did so with high levels of consistency
across the 3 datasets. Additional application of this approach
to the GTEx (Genotype-Tissue Expression project) human liver
RNAseq data identified 56 genes, of which 11 were prioritized
for functional validation studies in human hepatoma cell lines.
From this analysis, we identified gene glyoxalase I (GLO1),
with expression levels that are highly correlated with known
cholesterol-related genes. More importantly, in a follow-up
wet laboratory experiment, we found that GLO1 knockdown
increased levels of cellular cholesterol esters. In addition, we
performed pantissue analysis by applying GeneFishing to GTEx
expression data from a large collection of tissues and identified
many potential tissue-specific cholesterol metabolism-related
genes. These findings demonstrate the ability of GeneFishing to
identify genes relevant to previously defined biological pathways
in a context-specific manner. The strategy is obviously general-
izable to the study of other aspects of biological systems and
may be used across a wide range of applications outside biology.
Since our approach falls into the guilt by association paradigm,
we recognize that, as usual, association does not imply cau-
sation, and many of the genes that we point to may well be
involved with other functions of cholesterol than ones governing
metabolism.
Results
A Motivating Example. A major challenge of genome-wide anal-
yses is how to extract sparse signals from large-scale datasets,
which tend to be heterogeneous and noisy. To illustrate how
the level of noise in the data increases the complexity of detect-
ing genes involved in a specific biological process, we performed
a simple study of the cholesterol metabolic process using tran-
scriptomic measures from 426 LCLs (lymphoblastoid cell lines)
derived from participants of the CAP (Cholesterol and Pharma-
cogenetics) statin clinical trial (13) (CAP-LCLs). This is one of
the major datasets that we use in this paper to demonstrate the
performance of our GeneFishing method.
From Ensembl BioMart (https://www.ensembl.org/biomart/
martview/7f44660a1147fceb60a6845325da0ca5), we extracted
120 genes that are annotated with the GO BP (Gene Ontology
biological process) term “GO:0008203 cholesterol metabolic
process,” of which 82 are expressed in the CAP-LCL dataset.
We first measured coexpression of all gene pairs as the absolute
value of Spearman rank correlation of gene expression values
across subjects. Thus, our data can be thought of as a T × T
gene coexpression matrix (here, T = 82). We next performed
spectral analysis based on the coexpression matrix to project
each gene onto the space of the first 2 non-0 eigenvectors of the
normalized Laplacian matrix and identified a tight cluster of 21
genes (Fig. 1A), 18 of which encode enzymes in the cholesterol
biosynthesis pathway (14), with the remaining 3 genes known
to be involved in the transcriptional regulation of these 18
genes (i.e., INSIG1 and SREBF2) or complementary functions
(LDLR, the key regulator of low density lipoprotein [LDL]
uptake) (SI Appendix, Fig. S1 and Table S1). To test whether
this tight cluster persisted in the context of other genes, we
repeated the analysis using gene sets composed of the 21 genes
as well as 100, 1,500, and 2,000 random genes (Fig. 1 B to D).
Since the majority of genes should be unrelated to cholesterol
metabolism, we expect that the sheer number of pairs of such
genes outweighs those that show patterned relations among
our subjects. As shown in Fig. 1B, the 21 genes created an
obvious cluster when mixed with 100 random genes. However,
this cluster became obscured in the presence of larger sets of
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Fig. 1. Motivation and workflow of GeneFishing. (A to D) Spectral clustering plot of the 21 bait genes (colored in red) with another 61 genes (colored in
blue) associated with the GO BP term “cholesterol metabolic process” (A), and 100 (B), 1,500 (C), and 2,000 (D) random genes (colored in gray). (E) Workflow
of GeneFishing.
18944 | www.pnas.org/cgi/doi/10.1073/pnas.1820340116 Liu et al.
BI
O
PH
YS
IC
S
A
N
D
CO
M
PU
TA
TI
O
N
A
L
BI
O
LO
G
Y
ST
A
TI
ST
IC
S
random genes as shown in Fig. 1 C and D. These results illustrate
how the information provided by the 21 cholesterol genes is
progressively obscured by random noise patterns with increasing
numbers of random genes.
The GeneFishing Procedure. Our goal is to develop an effective
procedure to identify genes relevant to known biological pro-
cesses using transcriptomic data. Leveraging the clustering of the
21 cholesterol-related genes observed above, we develop Gene-
Fishing, a semisupervised, nonparametric clustering procedure
based on a bagging-like idea to reconstruct portraits of biolog-
ical processes of interest in varying context. The input data of
GeneFishing are an M × T matrix representing the normalized
expression values of T genes across M subjects together with a
small set of preidentified genes known to be relevant to the bio-
logical process of interest (such as the 21 genes mentioned in
the motivating example). This set of genes can be used as “bait”
genes to guide our search for additional genes that are potentially
relevant to the biological process.
The GeneFishing flowchart is shown in Fig. 1E. Given bait
genes, step 1, reduction of search space, is key in our method,
facilitating the pulling of “signal” out of the “noise.” In particu-
lar, the candidate genes are randomly split into many subsearch
spaces of m genes each (e.g., m = 100). The bait genes are then
added to each of the candidate gene subsets. In step 2, coex-
pression matrices are constructed for gene pairs contained within
each subsearch space, and the spectral clustering algorithm was
applied to each matrix separately. The current implementation
uses Spearman rank correlation to generate gene coexpression
matrices. Other coexpression measures can be more appropriate
in other contexts as discussed in refs. 15–17. While in most cases,
the bait genes cluster separately from the candidate genes, in
some instances candidate gene(s) will cluster with the bait genes
(e.g., when a gray dot clusters within the red dots as shown in
Fig. 1B). When this occurs, we consider the candidate gene to
be “fished out.” Since a candidate gene may randomly cocluster
with the bait genes, we repeat steps 1 and 2 (defining 1 round
of GeneFishing) n times (e.g., n = 1000). In step 3, the results
from all rounds are aggregated. The final output is a table that
records the “capture frequency rate” (CFR; the ratio of the num-
ber of times that each candidate gene has been fished out in the
n rounds of GeneFishing to n). We consider fished out genes
with large CFR values as “discoveries.” Note, however, that we
can only conclude that these discoveries are likely functionally
related to the bait genes, not that they perform a specific or sim-
ilar function as the bait genes. Complete technical details of the
GeneFishing procedure as well as the computation of approxi-
mate P values and false discovery rates (FDRs) are provided in
Methods and SI Appendix.
Evaluating GeneFishing with Real and Simulated Datasets. All statis-
tical models (or methods) in genomics are crude approximations
to reality. They are used to generate procedures and provide
measures using model-based inferences of the potential valid-
ity of perceived findings. In the usual case when we lack reliable
models for some of the biological systems of interest, we focus
on 3 minimum requirements: interpretability, replicability, and
stability (18). By interpretability, we mean that some of the
results can be related to known biology and ideally, guide fur-
ther experimental study. Replicability refers to the stability of
conclusions when the same methodology is applied to similar
independent datasets. Stability means that conclusions should
vary little under small statistical perturbations of the data and
the model.
Interpretability. We first assessed whether the discoveries
derived from GeneFishing were biologically plausible. Since
genes involved in sterol metabolism are themselves well known
to be transcriptionally coregulated, we used the 21 genes dis-
cussed in our motivating example as bait genes and applied
GeneFishing to the CAP-LCL dataset. We noted that the CFR
distribution of GeneFishing was strongly bimodal, which indi-
cates a very natural cutoff for CFR (Fig. 2A). Finally, we
identified 27 genes with CFR ≥ 0.99 (SI Appendix, Table S2).
Interestingly, 10 of these had known roles in lipid or sterol
metabolism and included TMEM55B, which we had previously
identified as a cholesterol-regulatory gene based on its very high
degree of coexpression with HMGCR, 1 of the 21 bait genes (19).
Replicability. To assess replicability, we tested the performance
of GeneFishing in 2 other independent LCL datasets: the
GEUVADIS-LCL (20) (462 lymphoblastoid cell lines from
Genetic European Variation in Disease project) dataset and
the GTEx-LCL (4) dataset (118 lymphoblastoid cell lines from
GTEx project). We first checked the expression of the 21 bait
genes in both datasets and observed clear clustering of the 21
genes again by spectral analysis (SI Appendix, Fig. S2 A and
B). We then applied GeneFishing to each dataset using the 21
genes as bait and tested the overlap within the top t fished
out genes (ordered by CFR values with t varying from 20 to
100) between the 3 (CAP, GEUVADIS, and GTEx). For bench-
marking purposes, we also compared GeneFishing with other
methods, including WGCNA (21) (weighted correlation network
analysis, an unsupervised approach for finding gene coexpres-
sion clusters) and 3 different versions of guilt by association
approaches (i.e., the association between a candidate gene and
the set of bait genes is evaluated by the mean, median, and max-
imum of the Spearman rank correlations between the candidate
and each of the bait genes, respectively). Of the methods tested,
GeneFishing had the best (or equally good) replicability (Fig. 2B
and SI Appendix, Fig. S2C).
Stability. Using the CAP-LCL dataset, we assessed the stability
of GeneFishing under the following 3 scenarios: (i) when ran-
dom genes are included in the set of bait genes (i.e., there is
noise in the bait set), (ii) when only a subset of the 21 genes is
used as baits, and (iii) when the method is applied to subsam-
ples of all subjects (e.g., 80% of subjects were used to construct
a gene–gene coexpression matrix when performing GeneFish-
ing). As shown in Fig. 2C, the CFR values of each scenario were
reasonably correlated with that derived from original CAP-LCL
dataset, especially for high CFRs (e.g., when CFR > 0.9). This
suggests that GeneFishing is quite robust to small perturbations
of the input dataset. We also performed a simulation study to
further investigate the stability of GeneFishing, and the results
are presented in SI Appendix.
Application of GeneFishing to Liver and a Follow-Up Wet Laboratory
Experiment Implicate GLO1 as a Cholesterol Metabolism Regulator.
Since the liver is the major organ that impacts plasma choles-
terol, we applied GeneFishing to the GTEx human liver RNAseq
dataset (119 samples). After confirming clear clustering of the 21
bait genes (SI Appendix, Fig. S3A), we identified 56 genes with
a CFR ≥ 0.99 (SI Appendix, Table S3). GO term enrichment
analysis (with R package GOStats) (22) identified substantial
enrichment for multiple GO terms related to sterol metabolism,
including “lipid metabolic process” (FDR = 7.56E-09) and “lipid
biosynthetic process” (FDR = 5.29E-07). Next, since many genes
involved in cholesterol metabolism are themselves transcrip-
tionally regulated by cellular sterols, we sought to determine if
any of the 56 genes showed evidence of sterol regulation. We
performed transcriptome-wide sequencing on HepG2 cells that
were first sterol depleted (incubated with 2 µM simvastatin +
10% lipoprotein-deficient serum for 24 h), after which 50 µg/mL
low-density lipoprotein cholesterol (LDLC) was added back and
incubated for an additional 24 h. Of the 56 genes, transcript
levels of 28 genes were changed in response to sterol deple-
tion (adjusted P value < 0.05), with effects reversed by LDLC
add back (SI Appendix, Table S3). Interestingly, 13 of the 56
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Fig. 2. Evaluation of GeneFishing. (A) Distribution of CFR values when GeneFishing was applied to the CAP-LCL dataset. (B) For each method, 2 ranked gene
lists were generated by applying the method to the CAP-LCL and GEUVADIS-LCL datasets. Each colored curve corresponds to a gene prioritization method,
plotting the number of overlapped genes between the 2 lists up to a rank position (y axis) against the rank (x axis). GBA is short for guilt-by-association.
(C) Scatterplots of the CFR values when GeneFishing was applied to the raw CAP-LCL dataset and 3 randomly perturbed datasets.
genes did not appear to be changed in response to sterol deple-
tion (P value> 0.5); 6 of the 56 genes were not expressed at
a high-enough level in the HepG2 cells to meet the minimum
threshold for expression. Several of the genes identified (e.g.,
MMAB, SNAI3-AS1) appeared to share promoter elements with
1 of the 21 bait genes (SI Appendix, Fig. S3B).
Of the genes not previously implicated in cholesterol
metabolism, we tested the effect of knockdown of 11 of these
genes on measures of intracellular cholesterol. We purposefully
selected some genes that showed no evidence of sterol regula-
tion (e.g., GLO1, TDRKH, TTC39B, and C2orf82) (Fig. 3A), as
the reason why and/or how these genes may have been identified
by GeneFishing was unclear. Huh7 cells were reverse transfected
with siRNAs (silencing RNAs) targeting each gene of inter-
est or a nontargeting control siRNA, and after 48 h, changes
in gene expression and cellular cholesterol were quantified by
qPCR and via the Amplex Red Cholesterol assay, respectively
(Fig. 3A). Knockdown of 2 genes, GLO1 and RDH11, signif-
icantly impacted transcript levels of SQLE, which encodes an
enzyme in the cholesterol synthesis pathway (Fig. 3B). This
change was confirmed in a second human hepatoma cell line,
HepG2 (Fig. 3C). In addition, consistent with the increase in
SQLE levels, we found that GLO1 knockdown significantly
increased cellular cholesterol esters in both Huh7 and HepG2
cells (Fig. 3D).
Pantissue GeneFishing Analysis. The cholesterol metabolic process
functions widely in different human tissues. Motivated by the
success of GeneFishing in the application to the GTEx liver data,
we next sought to determine if the strong clustering of the 21
bait genes was also observed in other tissue types. In more detail,
given a tissue, we performed the same spectral clustering analy-
sis as in Fig. 1A and computed 2 statistics: tightness (defined as
the ratio between within-cluster sum-of-squares and total sum-
of-squares) of the cluster that contains most of the 21 genes and
Jaccard index between the cluster and the 21 bait genes. Most
tissues exhibited the 21 genes as a tight cluster. However, the
21-gene module was not apparent in some tissues due either to
stronger coexpression with genes outside of the 21-gene mod-
ule (e.g., adrenal gland) or to complete absence of coexpression
(e.g., skeletal muscle) (Fig. 4B). Although it is well established
that genes in the cholesterol synthesis pathway are coregulated,
the change in their coexpression pattern that we observed across
different tissues indicates an unexpectedly high degree of tissue
specificity of such coregulation and meanwhile, may inform their
unknown functions (or interesting connections of the cholesterol
synthesis pathway to other biological processes).
To construct a somewhat global picture of cholesterol
metabolism as well as its potential cross-talk with other biological
processes, we next applied GeneFishing to the 17 GTEx tissues
in which the coexpression pattern of the 21 genes was well main-
tained. In the previous sections, when generating candidate gene
lists for experimental validation, we used a very strict CFR≥ 0.99
threshold; here, we loosened the cutoff to 0.9, as the coexpres-
sion strength between bait genes and genes that are functionally
linked to lipid metabolism are strongest in the liver as compared
to other tissues. We discuss in SI Appendix that much lower cut-
off points than 0.9 are still likely to correspond to very low FDR.
In total, 329 genes were identified with a CFR larger than 0.9 in
at least 1 tissue (SI Appendix, Table S4). Almost 74% (246 genes)
of these were identified in only 1 tissue, while only 7.5% (28
genes) were identified in at least 8 tissues, illustrating that there
is a high degree of tissue specificity. Tissue-specific GO enrich-
ment analysis of the 329 genes identified 52 GO BP terms, each
of which is significant in at least 1 tissue (FDR < 0.001). Inter-
estingly, all of the 52 GO BP terms were child terms of the
18946 | www.pnas.org/cgi/doi/10.1073/pnas.1820340116 Liu et al.
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Fig. 3. Effect of candidate gene knockdown on transcript levels of cholesterol related genes. (A) Transcript levels (in the Huh7 cell line) of candidate genes
were quantified by SYBR Green assay via qPCR to assess the degree of gene knockdown. (B) Transcript level of SQLE (in the Huh7 cell line) was quantified
by SYBR Green assay to test whether candidate genes knockdown modulated its expression level. (C) Transcript levels (in the HepG2 cell line) of GLO1
and RDH11 were quantified by SYBR Green assay via qPCR to assess the degree of gene knockdown. Transcript level of SQLE (in the HepG2 cell line) was
quantified by SYBR Green assay to test whether GLO1 and RDH11 knockdown modulated its expression level. In A to C, data were analyzed using the
delta Ct (cycle threshold) method and normalized to CLPTM1 transcript levels as a loading control. All qPCR assays were performed in triplicate. (D) Cellular
cholesterol levels were quantified using the Amplex Red Cholesterol Assay kit with values normalized to total cellular protein quantified via Bradford assay.
There are 3 to 6 replicates per treatment condition. NTC, nontargeting control.
“GO:0008152 metabolic process” (SI Appendix, Table S5). As
expected, “GO:0006629 lipid metabolic process” was enriched in
the genes identified in all of the 17 tissues. We also performed
hierarchical clustering based on the GO enrichment profile and
found that 6 tissues (artery–aorta, artery–tibial, whole blood, thy-
roid, pancreas, and stomach) seemed to be distinct from the
remaining 11 tissues due to a depletion of the GO terms that
were broadly enriched in other tissues (SI Appendix, Fig. S4). For
example, while “GO:0006641 triglyceride metabolic process” was
identified in 10 of the other 11 tissues, it was not enriched in any
of the 6 tissues mentioned above.
Comparing GeneFishing with GIANT and ENDEAVOUR. Two popular
methods, GIANT and ENDEAVOUR, were proposed before
our study, and both of them have been widely used for gene pri-
oritization. Although differing in key aspects from GeneFishing,
the 3 methods share identical input–output schema: they all
accept a group of seed (or bait) genes that are related to
a biological process as input and return a list of genes that
have been ranked according to computed functional relevance.
We ranked all GTEx liver-expressed genes with GIANT and
ENDEAVOUR. Since liver is the tissue that plays an impor-
tant role in lipid metabolism and the 21 bait genes are all related
to cholesterol metabolism, it is reasonable to expect that, in the
returned gene list from any of the 3 gene prioritization methods,
lipid metabolism-related genes should have high rankings. We
found that GeneFishing captured the highest number of genes
associated with the GO BP term “lipid metabolic process” among
its top-ranked genes, demonstrating its superiority to the other
2 methods, at least in this application (Fig. 5). When compared
with ENDEAVOUR, GeneFishing did substantially better in the
identification of lipid-related genes. Although a similarly high
number of lipid-related genes is found among the first 25 genes
as ranked by our method and GIANT separately, our method
outperforms GIANT substantially from then on. Interestingly,
we found that gene PCSK9, a promising drug target to lower
the LDLC level (which is also an SREBF2 target gene) (23),
was fished out (with CFR = 1) by GeneFishing, while its pri-
ority rank in the ranked list of candidate genes by GIANT was
low (rank 6,102). In addition, the distribution of functional rel-
evance measure returned by GIANT did not show as strong of
bimodality as GeneFishing, suggesting that the calibration of
the GIANT scores seems quite inferior to ours (SI Appendix,
Fig. S5). We note that GIANT and ENDEAVOUR attempt to
incorporate multiple sources of data (such as gene expression,
protein–protein interaction, DNA sequence) to perform gene
prioritization. They thus have large advantages in terms of broad
applicability. However, as we demonstrate here, the generality
of the information that they use may lead them to miss patterns
specifically related to the biological question of interest. This is
consistent with the phenomenon that we observed in Fig. 1 (in
which inclusions of too much input data or noisy candidate genes
obscure signal) and that we believe accounts for the mediocre
performance of “all-purpose systems” in this task.
Discussion
In this paper, we developed a method we call GeneFishing. Our
goal is to reveal potential relations between genes and gene
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Fig. 4. Pantissue GeneFishing analysis. (A) Examination of modularity of the 21 bait genes across GTEx tissues. GeneFishing was applied to the 17 tissues
inside the blue circle. The Inset shows the detailed coordinates of the 17 tissues. (B) The coexpression pattern of the genes associated with the GO BP term
cholesterol metabolic process in 6 representative tissues. In each heat map, the row and column have identical gene orders, and the side bar indicates
whether the gene belongs to the 21 bait genes (red means yes). (C) Visualization of pantissue GeneFishing results. Each row is associated with a gene, and
each column is associated with a tissue (labeled with different colors). If the color of an entry is not gray, then it means that the CFR of the corresponding
gene is higher than 0.9 in the corresponding tissue.
pathways. We applied this method to cholesterol-related genes
and identified several interesting phenomena.
Applying GeneFishing to the GTEx liver dataset, we identi-
fied GLO1 as a gene not previously implicated in cholesterol
metabolism. Notably, murine models of GLO1 knockdown and
overexpression have reported conflicting results in regard to
whether GLO1 alters cholesterol metabolism in vivo. A GLO1
transgenic ApoE−/− model was reported to have increased
plasma cholesterol (24), while no change in lipids was observed
in a second transgenic model in which GLO1 was knocked down
(25). Thus, our findings of increased cholesterol ester on GLO1
knockdown in human liver-derived cell lines demonstrated that
additional study is warranted to evaluate the role of GLO1 in
cholesterol metabolism.
We made an interesting observation when applying Gene-
Fishing to the GTEx tissue dataset. Unlike most tissues, there
is a striking lack of coexpression of the 21 cholesterol-related
bait genes in the skeletal muscle dataset. In fact, they were not
coexpressed with any of the 120 cholesterol metabolism genes
annotated from BioMart (Fig. 4B). Since the 21 bait genes are
well-known targets of SREBF2, a cholesterol-regulated tran-
scription factor, this lack of coexpression suggests that, unlike
other tissues, SREBF2 may not be the major driver of expres-
sion of these 21 genes in the skeletal muscle. Statins, a class
of cholesterol-lowering drug, function in part through the acti-
vation of SREBF2. Thus, the potential lesser importance of
SREBF2 in the regulation of the 21 bait genes may be relevant
to the molecular mechanism underlying statin-induced myopa-
thy, one of the most common adverse effects of statin treat-
ment. Since statins also inhibit the production of isoprenoids
and ubiquinone (i.e., coenzyme Q), our findings support fur-
ther mechanistic studies that look beyond the role of SREBF2-
mediated effects during the development of statin-induced
myopathy.
The success of GeneFishing in the study of the choles-
terol metabolic process illustrates how our method may reveal
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Fig. 5. In both panels, each colored curve corresponds to a method, with x
axis representing the rank and the y axis representing the number of lipid
metabolism genes among the top-ranked genes.
biology worthy of additional investigation. Importantly, com-
pared with other methods, GeneFishing has the following advan-
tages. (i) It is robust against noise in the bait genes. Through
our evaluation on real and simulated data, as long as the
majority of the bait genes are functionally active in relation
to the biological process of interest, our procedure is rea-
sonably effective in finding other relevant active genes. (ii) It
provides reliable, interpretable measures of importance. (iii)
It is computationally cheap and easy to parallelize and there-
fore, can easily handle genome-wide analyses. (iv) It is flexible,
requiring only an appropriate set of bait genes and expres-
sion (or other measurements) on all genes for a set of subjects
(or conditions). (v) It is simple and can easily incorporate
other information, such as genetic variants or measures from
other assays, at the dimensionality reduction or clustering stage
to improve the relevance assessment of candidate genes to
bait genes.
Our method is easily extendable to an iterative version (that
we could call “iterative GeneFishing”), in which the discoveries
may be added back to the bait set and the algorithm continued
until some stopping criterion is satisfied. This might provide
a tool for continued exploration of possible relations between
processes in the same or different tissues.
In summary, GeneFishing is a powerful tool for reconstructing
comprehensive context-specific portraits of biological processes
and should be usable across a wide range of applications inside
and outside of biology.
Methods
Data Collection and Processing. Multiple RNAseq datasets were used in this
study. Preprocessed RNAseq data (version v6p) were downloaded from the
GTEx data portal (https://gtexportal.org/home/) (4). RNAseq data of the
LCL cell lines from GEUVADIS were downloaded from ArrayExpress (https://
www.ebi.ac.uk/arrayexpress/experiments/E-GEUV-1/) (20). In addition to the
above 2 datasets, we obtained the RNAseq data (of LCL cell lines) generated
by the CAP project (13) from dbGap (accession no. phs000481.v2.p1). For
each dataset, we removed genes with median RPKM (reads per kilobase per
million mapped reads) or FPKM (fragments per kilobase per million mapped
reads) value that is less than 0.1 and then, applied the PEER (26) software
(number of hidden factors is 25) on log-transformed RPKM (or FPKM) value
(with a pseudocount 0.01 added) to normalize the data.
Spectral Analysis for Dimension Reduction in GeneFishing. Given an M × T
matrix, which contains the expression values of T genes across M samples,
we first compute a T × T similarity matrix A with entry A[i,j] representing
the absolute value of Spearman rank correlation between gene i and gene j
across the M samples (note that alternative gene coexpression or association
measures, such as those introduced and discussed in refs. 15–17, can be used
per users’ choice and study goal). Next, we performed an eigen decomposi-
tion of the normalized graph Laplacian L = I − D−1/2AD−1/2 and formed a
T × K matrix G with column G[, j] representing the eigenvector correspond-
ing to the jth smallest non-0 eigenvalue of L. Here, D is a diagonal matrix in
which entry D[i,i] is the sum of the ith row of A. The matrix G thus provides
a representation of the T genes in a space with reduced dimension (i.e., K
dimensions). For the results presented in this article, we used K = 2. The
spectral analysis method used here is based on the method proposed by Ng
et al. in 2001 (27). The 2 clusters were determined by a K-means algorithm
(SI Appendix has more details).
The “P value” for Individual Genes. The random partitioning of the space of
genes that we perform gives us an initial solid basis for assigning P values
(e.g., using an approximated binomial distribution) or some other measure
of importance to fished out genes that can be used for prioritization. With
the partitioning procedure being carried out multiple times, a natural mea-
sure of the relevance of a gene is the CFR. In some situations, the number of
genes prioritized is not sensitive to the choice of CFR threshold. For exam-
ple, in the case of CAP-LCL (Fig. 1A), choosing arbitrarily high CFR thresholds
would result in a similar number of fished out genes. This is the case for
most but not all tissues. An example, artery–coronary tissue, is discussed in
SI Appendix (SI Appendix, Fig. S6). We also discuss various possible ways of
calculating P values and FDR values in such cases in SI Appendix. In the analy-
sis of liver tissue data, we found that a cutoff at CFR = 0.99 was a safe choice
to select the candidates to follow-up. In the pantissue analysis, a cutoff at
CFR = 0.9 seemed adequate.
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